Infinergy announces potential major local consumer for Furness Wind Farm energy

Infinergy announced today that a major local pharmaceutical site has expressed an interest in purchasing green electricity from the proposed Furness Wind Farm.

The company is having discussions with GlaxoSmithKline’s Ulverston site which is looking at options to source green power for its Cumbrian manufacturing facility where it makes active pharmaceutical ingredients for antibiotics.

Furness Wind Farm is a partnership project between Infinergy and community cooperative Baywind, which is seeking planning permission to repower Baywind’s existing five Harlock Hill wind turbines with five new machines.

GSK requires a reliable source of power for its Ulverston factory, where it employs around 240 staff. As a company, GSK has ambitious global environmental targets, including becoming carbon neutral, and is looking at green energy options at many of its operations.

If the proposed Furness Wind Farm gets the go ahead, Infinergy would own three wind turbines and Baywind would own two. GSK Ulverston potentially could use all of the electricity from Infinergy’s three new turbines, which could have an installed capacity of up to 6.9 megawatts. The annual power output of these turbines could reduce the GSK site’s carbon footprint by approximately 25 per cent.

A GSK spokesman said that looking to purchase green electricity from the Furness Wind Farm fitted well with the company’s sustainability strategy.

“In line with the company’s global drive to be more sustainable, GSK Ulverston has a target of reducing the site’s carbon footprint by 30 per cent by the end of 2014 compared with 2011”, the spokesman commented. “The Furness Wind Farm presents GSK with an opportunity to achieve this ambition.

“Competitively priced energy will also help to improve the site’s overall operating costs, enhancing Ulverston’s ability to increase output of active ingredients for antibiotics to take advantage of a growing global market.”

A Baywind spokesperson said, “GSK’s interest in Furness Wind Farm is fantastic news and we wholeheartedly welcome their support for the proposal. The involvement of a major Ulverston employer further strengthens the local benefits of the scheme. Through Baywind, local residents will also be offered the opportunity to buy affordable shares in the project.”

At Infinergy we are very excited about the prospect of welcoming GSK Ulverston on board. With Baywind’s involvement, who are based in Barrow and whose 1300 strong membership counts many local residents, GSK Ulverston’s involvement further enhances the local benefits of the wind farm. This opportunity allows us to not only contribute to national targets of 15% renewable energy by 2020, but to maximise local benefits too!

<< Back to news